Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

Clinical trial NCT01282632 · COMPLETED

Trial details

NCT number: NCT01282632
Sponsor: Sunnybrook Health Sciences Centre
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Subjects Had Unipolar, Non-psychotic Major Depression

Start date: 2002-08-01
Primary completion: 2004-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.